Latest Announcements

Nuvama Wealth Management Limited has informed the Exchange about Schedule of meet for Analysts/Institutional Investor Meeting(s) on November 16 and 26, 2026, where the company's representatives will discuss the Investor Presentation for the quarter and half year ended September 30, 2026.

Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of Analyst/ Institutional Investor meetings to be conducted from November 16, 2026 to November 18, 2026 in Taiwan and Singapore, and on November 23, 2026 in Switzerland.

Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of Analyst/ Institutional Investor meetings to be conducted from November 16, 2026 to November 18, 2026 in Taiwan and Singapore, and on November 23, 2026 in Switzerland. The meetings may undergo changes due to exigencies.

Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of an Analyst/ Institutional Investor meeting to be conducted from November 16-18, 2026, in Taiwan and Singapore, and on November 23, 2026, in Switzerland. The meeting will be held for both physical and one-on-one meetings with investors.

Glenmark Pharmaceuticals Limited has informed the Exchange about the schedule of Analyst/ Institutional Investor meetings to be conducted between November 16, 2026, and November 23, 2026, in Taiwan, Singapore, and Switzerland. The meetings will be conducted both physically and virtually, and no unpublished price-sensitive information will be shared during the meetings.

Xpro India Limited hosted an earnings conference call for Q2 and H1 FY27, discussing their results and key developments. The company's Managing Director, C. Bhaskar, introduced the call and highlighted their diversified multi-locational business, primarily focused on polymer processing. Xpro has manufacturing facilities in India and the UAE, and specializes in advanced materials, including polypropylene dielectric capacitor films. The company's results for the quarter and half year ended September 30, 2026, have been uploaded to stock exchange portals and their website.

Avenue Supermarts Ltd has repaid its commercial paper worth Rs. 300 Crores on November 9, 2026, as per the SEBI Master Circular.

Alufluoride Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2026.

Vinati Organics Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Suchir Chemicals Pvt Ltd.

Regaal Resources Ltd has announced the schedule of its earnings conference call for Q2 & H1 FY27, to be held on November 16, 2026, at 11:30 A.M. The call will be represented by the company's management, including the Chairman and Managing Director, Whole-time Director, and Chief Financial Officer.

Whirlpool of India Limited has submitted its financial results for the quarter and half year ended September 30, 2026, to the National Stock Exchange of India Limited.

Jyothy Labs Limited has informed the Exchange regarding 'Addendum to Public Announcement - Buyback of Equity Shares of the Company'. The company has increased the buyback price from ₹ 215 to ₹ 240 per equity share and decreased the maximum number of equity shares proposed to be bought back from 68,37,210 to 61,25,000.

Vinati Organics Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suchir Chemicals Pvt Ltd

KSH International Limited has informed the Exchange about the schedule of a meeting with analysts and institutional investors.

Chembond Chemicals Ltd's promoter, Nirmal V. Shah, has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, revealing the purchase of 2,521 equity shares of the company. This acquisition brings Shah's total holding to 72,32,976 shares, representing 26.89% of the company's total share capital.

RDB Rasayans Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the un-audited financial results for the quarter and half year ended 30th September, 2026.

Aptus Value Housing Finance India Ltd has informed the exchanges about an investor/analyst meet scheduled for November 11, 2026, with Morgan Stanley. The meeting will be virtual and one-on-one. The company has also uploaded its investor presentation on its website.

Jyothy Labs Ltd has increased the buyback price from ₹ 215 to ₹ 240 per equity share and decreased the maximum number of equity shares to be bought back from 68,37,210 to 61,25,000, representing up to 1.67% of the total number of equity shares in the paid-up share capital of the company.

Cochin Shipyard Ltd has announced the results of a postal ballot conducted through remote e-voting, where two resolutions were passed with requisite majority. The first resolution relates to the transfer of the ISRF undertaking, and the second resolution concerns a material related party transaction with a joint venture company.

Glenmark Pharmaceuticals Ltd has uploaded the transcript of its earnings call on its website, as per Regulation 30(6) of SEBI (LODR), Regulations 2015.